DAVID SETH FELDMAN

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting
    David S Feldman
    Division of Cardiology, The Ohio State University Medical Center, Columbus, OH 43210, USA
    Heart Fail Rev 9:203-8. 2004
  2. ncbi Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure
    David S Feldman
    Davis Heart and Lung Research Institute, Division of Cardiology Medicine, Ohio State University, Columbus, OH 43210, USA
    Nat Clin Pract Cardiovasc Med 2:475-83. 2005

Research Grants

  1. Adrenergically Mediated Remodeling in Nonischemic Heart Failure
    David Feldman; Fiscal Year: 2007

Detail Information

Publications2

  1. ncbi Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting
    David S Feldman
    Division of Cardiology, The Ohio State University Medical Center, Columbus, OH 43210, USA
    Heart Fail Rev 9:203-8. 2004
    ..Overall, nesiritide appears to be an effective and safe therapeutic option in perioperative patients with decompensated heart failure...
  2. ncbi Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure
    David S Feldman
    Davis Heart and Lung Research Institute, Division of Cardiology Medicine, Ohio State University, Columbus, OH 43210, USA
    Nat Clin Pract Cardiovasc Med 2:475-83. 2005
    ..In this review, we summarize current insights into beta-adrenergic signal-transduction pathways, the best-described beta-AR polymorphisms, and therapies that target the beta-AR pathway in HF...

Research Grants1

  1. Adrenergically Mediated Remodeling in Nonischemic Heart Failure
    David Feldman; Fiscal Year: 2007
    ..The successful completion of this research will contribute to our understanding of beta-2-ARs signaling and reverse remodeling in chronic HF, and provide a better insight into the mechanisms of CRT and beta- blocker therapy. ..